Tg Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
TGTX chart
What traders are saying about $TGTX
Latest postsTg Therapeutics, Inc. news
- TG Therapeutics (TGTX) Lifts Revenue Guidance As Investors Ask If The Stock Is Pricey
Yahoo Finance ·
- TG Therapeutics (TGTX) Stock Stays Hard To Justify Despite Raised Revenue Guidance
Yahoo Finance ·
- How IBD Stock Of The Day TG Therapeutics Is Catching Up To Roche, Novartis
Yahoo Finance ·
- How Stock Of The Day TG Therapeutics Is Making Waves For Its Rivals
Investor's Business Daily ·
- Is Earnings Beat Altering The Investment Case For TG Therapeutics (TGTX)?
Yahoo Finance ·
- TG Therapeutics raises 2026 revenue outlook to about $1 billion on Briumvi growth
MLQ.ai ·
- TGTX Q3 Earnings & Revenues Beat Estimates, 2026 View Raised, Stock Up
Yahoo Finance ·
- TG Therapeutics (NASDAQ:TGTX) Q3 2026: BRIUMVI Lifts Guidance
Kalkine Media ·
- TG Therapeutics stock hits 52-week high at 63.68 USD
Investing.com ·
- TG Therapeutics stock hits 52-week high at 63.68 USD By Investing.com
Investing.com UK ·
- IBRX Q3 Earnings Miss, Anktiva Sales Decline Q/Q, Stock Down 18%
Yahoo Finance ·
- CRMD to Acquire HRTX Assets for $223M Upfront to Expand Portfolio
Yahoo Finance ·
Tg Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $616.3M | $329.0M | $233.7M | $2.8M |
| Net income | $447.2M | $23.4M | $12.7M | -$198.3M |
| Diluted EPS | $2.77 | $0.15 | $0.09 | $-1.65 |
| Total assets (year end) | $1.06B | $577.7M | $329.6M | $193.6M |
| Cash and equivalents (year end) | $79.1M | $179.9M | $92.9M | $102.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Tg Therapeutics, Inc.
- Ticker
- TGTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1001316
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
Frequently asked questions
What exchange is Tg Therapeutics, Inc. listed on?
Tg Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TGTX.
What industry is Tg Therapeutics, Inc. in?
Tg Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Tg Therapeutics, Inc. headquartered?
Tg Therapeutics, Inc.'s business address on file with the SEC is in New York, NY.
When does Tg Therapeutics, Inc.'s fiscal year end?
Tg Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Tg Therapeutics, Inc. report?
Tg Therapeutics, Inc. reported $616.3M in revenue for calendar year 2025, according to its SEC filings.